Search by Drug Name or NDC
NDC 63323-0965-05 Potassium Chloride 2 meq/mL Details
Potassium Chloride 2 meq/mL
Potassium Chloride is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is POTASSIUM CHLORIDE.
Product Information
| NDC | 63323-0965 |
|---|---|
| Product ID | 63323-965_a1b31b46-2bb4-457e-a30b-e7dab47a2c54 |
| Associated GPIs | 79700030002005 |
| GCN Sequence Number | 001255 |
| GCN Sequence Number Description | potassium chloride VIAL 2 MEQ/ML INTRAVEN |
| HIC3 | C1D |
| HIC3 Description | POTASSIUM REPLACEMENT |
| GCN | 03350 |
| HICL Sequence Number | 000549 |
| HICL Sequence Number Description | POTASSIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Potassium Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | POTASSIUM CHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | meq/mL |
| Substance Name | POTASSIUM CHLORIDE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA088901 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0965-05 (63323096505)
| NDC Package Code | 63323-965-05 |
|---|---|
| Billing NDC | 63323096505 |
| Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-965-05) / 5 mL in 1 VIAL, SINGLE-DOSE (63323-965-01) |
| Marketing Start Date | 1999-09-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |